Breaking News Instant updates and real-time market news.

TMUS

T-Mobile

$143.91 /

+1.51 (+1.06%)

11:15
06/04/21
06/04
11:15
06/04/21
11:15

T-Mobile participates in a conference call with UBS

Media & Telecom Analyst Hodulik and Technology Analyst Levi hold a conference call with Neville Ray, President of Technology, who will discuss the future of 5G on June 4 at 11:30 am hosted by UBS.

  • 04

    Jun

  • 24

    Jun

TMUS T-Mobile
$143.91 /

+1.51 (+1.06%)

05/27/21
Fly Intel: Top five analyst initiations
05/27/21 Benchmark
Benchmark starts T-Mobile at Buy, sees 5G momentum as sustainable
05/27/21 Benchmark
T-Mobile initiated with a Buy at Benchmark
05/24/21 HSBC
T-Mobile price target raised to $139 from $132 at HSBC

TODAY'S FREE FLY STORIES

Upgrade
Parker-Hannifin upgraded to Overweight from Sector Weight at KeyBanc » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
PH

Parker-Hannifin

$289.40 /

+1.33 (+0.46%)

KeyBanc analyst Jeffrey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PH Parker-Hannifin
$289.40 /

+1.33 (+0.46%)

PH Parker-Hannifin
$289.40 /

+1.33 (+0.46%)

06/11/21 Baird
Parker-Hannifin end markets accelerating growth mode, says Baird
05/05/21 Argus
Parker-Hannifin price target raised to $345 from $310 at Argus
05/03/21 Barclays
Parker-Hannifin price target raised to $340 from $330 at Barclays
04/29/21 Goldman Sachs
Parker-Hannifin price target raised to $369 from $364 at Goldman Sachs
PH Parker-Hannifin
$289.40 /

+1.33 (+0.46%)

Conference/Events
Chemed management to meet virtually with Oppenheimer » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
CHE

Chemed

$480.09 /

+0.69 (+0.14%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHE Chemed
$480.09 /

+0.69 (+0.14%)

02/25/21 Oppenheimer
Chemed price target lowered to $580 from $600 at Oppenheimer
CHE Chemed
$480.09 /

+0.69 (+0.14%)

Conference/Events
GT Biopharma management to meet virtually with B. Riley » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
GTBP

GT Biopharma

$15.46 /

-1.08 (-6.53%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GTBP GT Biopharma
$15.46 /

-1.08 (-6.53%)

GTBP GT Biopharma
$15.46 /

-1.08 (-6.53%)

05/24/21 H.C. Wainwright
GT Biopharma initiated with a Buy at H.C. Wainwright
04/13/21 B. Riley
B. Riley starts GT Biopharma with Buy, sees 101% upside in shares
04/13/21 B. Riley
GT Biopharma initiated with a Buy at B. Riley
03/17/21 Roth Capital
GT Biopharma initiated with a Buy at Roth Capital
  • 11
    Feb
GTBP GT Biopharma
$15.46 /

-1.08 (-6.53%)

Conference/Events
Everbridge participates in a conference call with JPMorgan » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
EVBG

Everbridge

$131.34 /

+1.84 (+1.42%)

Software Analyst Auty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVBG Everbridge
$131.34 /

+1.84 (+1.42%)

EVBG Everbridge
$131.34 /

+1.84 (+1.42%)

06/17/21 Stephens
Everbridge assumed with an Overweight at Stephens
03/29/21 Credit Suisse
Everbridge assumed with a Neutral at Credit Suisse
02/19/21 JPMorgan
Everbridge upgraded to Overweight with $200 price target at JPMorgan
02/19/21 Northland
Everbridge price target raised to $165 from $155 at Northland
EVBG Everbridge
$131.34 /

+1.84 (+1.42%)

EVBG Everbridge
$131.34 /

+1.84 (+1.42%)

Conference/Events
Raymond James to hold a virtual conference » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
TFX

Teleflex

$404.93 /

+5.265 (+1.32%)

, CBAY

CymaBay

$4.48 /

-0.26 (-5.49%)

, PYPD

PolyPid

$8.91 /

-0.11 (-1.22%)

, AYLA

Ayala Pharmaceuticals

$11.00 /

+0.3 (+2.80%)

, BWAY

Brainsway

$10.30 /

-0.1 (-0.96%)

, ENTA

Enanta

$46.35 /

+0.18 (+0.39%)

, KDMN

Kadmon

$3.83 /

-0.16 (-4.01%)

, ONCS

OncoSec

$3.40 /

+ (+0.00%)

, ATHA

Athira Pharma

$10.33 /

-0.42 (-3.91%)

, QDEL

Quidel

$111.29 /

-0.5 (-0.45%)

, CYTK

Cytokinetics

$22.15 /

+0.38 (+1.75%)

, NGM

NGM Biopharmaceuticals

$20.37 /

+0.28 (+1.39%)

, MEDXF

Medexus Pharmaceuticals

$5.69 /

-0.06 (-1.04%)

, FLXN

Flexion

$8.86 /

-0.28 (-3.06%)

, HRMY

Harmony Biosciences

$31.17 /

-0.83 (-2.59%)

Human Health Innovation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TFX Teleflex
$404.93 /

+5.265 (+1.32%)

CBAY CymaBay
$4.48 /

-0.26 (-5.49%)

PYPD PolyPid
$8.91 /

-0.11 (-1.22%)

AYLA Ayala Pharmaceuticals
$11.00 /

+0.3 (+2.80%)

BWAY Brainsway
$10.30 /

-0.1 (-0.96%)

ENTA Enanta
$46.35 /

+0.18 (+0.39%)

KDMN Kadmon
$3.83 /

-0.16 (-4.01%)

ONCS OncoSec
$3.40 /

+ (+0.00%)

ATHA Athira Pharma
$10.33 /

-0.42 (-3.91%)

QDEL Quidel
$111.29 /

-0.5 (-0.45%)

CYTK Cytokinetics
$22.15 /

+0.38 (+1.75%)

NGM NGM Biopharmaceuticals
$20.37 /

+0.28 (+1.39%)

MEDXF Medexus Pharmaceuticals
$5.69 /

-0.06 (-1.04%)

FLXN Flexion
$8.86 /

-0.28 (-3.06%)

HRMY Harmony Biosciences
$31.17 /

-0.83 (-2.59%)

TFX Teleflex
$404.93 /

+5.265 (+1.32%)

05/18/21 Piper Sandler
Teleflex divestiture should accelerate sales growth, says Piper Sandler
05/10/21 Piper Sandler
Teleflex management surprised by post-earnings selloff, says Piper Sandler
04/30/21 SVB Leerink
Teleflex price target raised to $485 from $475 at SVB Leerink
02/25/21 Piper Sandler
Teleflex price target raised to $465 from $405 at Piper Sandler
CBAY CymaBay
$4.48 /

-0.26 (-5.49%)

06/21/21 Piper Sandler
Piper radar 'locked' on CymaBay EASL poster presentations on June 23
06/14/21 JonesTrading
JonesTrading starts CymaBay with Buy, $8 target on seladelpar potential
06/14/21 JonesTrading
CymaBay initiated with a Buy at JonesTrading
06/09/21 Piper Sandler
CymaBay to have 'impressive' lineup at EASL meeting, says Piper Sandler
PYPD PolyPid
$8.91 /

-0.11 (-1.22%)

11/24/20 Raymond James
Raymond James upgrades PolyPid to Strong Buy after BTD for D-PLEX
11/24/20 Raymond James
PolyPid upgraded to Strong Buy from Outperform at Raymond James
08/10/20 Alliance Global Partners
PolyPid initiated with a Buy at Alliance Global Partners
07/21/20 Raymond James
PolyPid initiated with an Outperform at Raymond James
AYLA Ayala Pharmaceuticals
$11.00 /

+0.3 (+2.80%)

12/07/20
Fly Intel: Top five analyst initiations
12/07/20 Roth Capital
Ayala Pharmaceuticals initiated with a Buy at Roth Capital
12/02/20
Fly Intel: Top five analyst initiations
12/02/20 Noble Capital
Ayala Pharmaceuticals initiated with an Outperform at Noble Capital
BWAY Brainsway
$10.30 /

-0.1 (-0.96%)

04/20/21 Northland
Brainsway initiated with an Outperform at Northland
02/17/21 Raymond James
Brainsway price target raised to $12 from $9 at Raymond James
ENTA Enanta
$46.35 /

+0.18 (+0.39%)

02/09/21 RBC Capital
Enanta price target raised to $53 from $47 at RBC Capital
01/29/21 JPMorgan
Enanta upgraded to Neutral with $55 target at JPMorgan
01/29/21 JPMorgan
Enanta upgraded to Neutral from Underweight at JPMorgan
01/08/21 Piper Sandler
Enanta remains 'significantly undervalued,' says Piper Sandler
KDMN Kadmon
$3.83 /

-0.16 (-4.01%)

06/04/21 Mizuho
Kadmon's KD022 results a positive start for immuno-oncology program, says Mizuho
05/20/21 UBS
Kadmon initiated with a Buy at UBS
03/11/21 Oppenheimer
Kadmon should be bought on weakness from FDA extension, says Oppenheimer
02/10/21 Jefferies
Survey points to 'encouraging' signs for Kadmon's belumosudil, says Jefferies
ONCS OncoSec
$3.40 /

+ (+0.00%)

04/15/21 Alliance Global Partners
OncoSec price target raised to $11 from $6.50 at Alliance Global Partners
03/25/21 Maxim
OncoSec price target raised to $12 from $8 at Maxim
03/08/21
Fly Intel: Top five analyst initiations
03/08/21 BTIG
OncoSec initiated with a Buy at BTIG
ATHA Athira Pharma
$10.33 /

-0.42 (-3.91%)

06/18/21 Jefferies
Athira Pharma's 'unusual situation' to cause some volatility, says Jefferies
06/18/21 Stifel
Athira Pharma CEO leave situation 'impossible to really vet,' says Stifel
06/07/21 JMP Securities
Aducanumab accelerated approval positive for Athira, others, says JMP Securities
06/07/21 Goldman Sachs
Goldman says Biogen approval has positive read to Alector, Athira
QDEL Quidel
$111.29 /

-0.5 (-0.45%)

06/17/21 Craig-Hallum
Quidel price target lowered to $219 from $296 at Craig-Hallum
06/04/21 JPMorgan
Quidel price target lowered to $80 from $90 at JPMorgan
05/07/21 JPMorgan
Quidel price target lowered to $90 from $95 at JPMorgan
04/23/21 JPMorgan
Quidel price target lowered to $95 from $120 at JPMorgan
CYTK Cytokinetics
$22.15 /

+0.38 (+1.75%)

05/11/21 Mizuho
Cytokinetics price target raised to $36 from $26 at Mizuho
03/11/21 Wolfe Research
Cytokinetics initiated with an Outperform at Wolfe Research
02/18/21 Barclays
Cytokinetics initiated with an Overweight at Barclays
01/20/21 H.C. Wainwright
Cytokinetics price target raised to $41 from $22 at H.C. Wainwright
NGM NGM Biopharmaceuticals
$20.37 /

+0.28 (+1.39%)

05/25/21 B. Riley
NGM 'disappointing failure' in NASH a 'clearing event,' says B. Riley
05/25/21 BMO Capital
NGM Biopharmaceuticals price target lowered to $20 from $38 at BMO Capital
05/25/21 Raymond James
Raymond James downgrades two NASH players following NGM data
05/24/21 Piper Sandler
Piper says Madrigal's MAESTRO-NASH outcome not impacted by NGM ALPINE data
MEDXF Medexus Pharmaceuticals
$5.69 /

-0.06 (-1.04%)

06/18/21 Canaccord
Medexus Pharmaceuticals price target lowered to C$9 from C$9.50 at Canaccord
03/03/21 Canaccord
Medexus Pharmaceuticals upgraded to Buy from Hold at Canaccord
02/24/21 Stifel
Medexus Pharmaceuticals price target raised to C$17.50 from C$7.25 at Stifel
FLXN Flexion
$8.86 /

-0.28 (-3.06%)

04/26/21 Credit Suisse
Flexion assumed with an Outperform at Credit Suisse
04/14/21 Raymond James
Flexion price target lowered to $16 from $18 at Raymond James
04/06/21 RBC Capital
Flexion transferred with an Outperform at RBC Capital
08/20/20 Goldman Sachs
Flexion initiated with a Neutral at Goldman Sachs
HRMY Harmony Biosciences
$31.17 /

-0.83 (-2.59%)

03/29/21 Goldman Sachs
Harmony Biosciences upgraded to Buy from Neutral at Goldman Sachs
09/14/20 Jefferies
Harmony Biosciences initiated with a Buy at Jefferies
09/14/20 Piper Sandler
Harmony Biosciences initiated with an Overweight at Piper Sandler
09/13/20 Goldman Sachs
Harmony Biosciences initiated with a Neutral at Goldman Sachs
TFX Teleflex
$404.93 /

+5.265 (+1.32%)

CBAY CymaBay
$4.48 /

-0.26 (-5.49%)

PYPD PolyPid
$8.91 /

-0.11 (-1.22%)

AYLA Ayala Pharmaceuticals
$11.00 /

+0.3 (+2.80%)

BWAY Brainsway
$10.30 /

-0.1 (-0.96%)

ENTA Enanta
$46.35 /

+0.18 (+0.39%)

ATHA Athira Pharma
$10.33 /

-0.42 (-3.91%)

QDEL Quidel
$111.29 /

-0.5 (-0.45%)

CYTK Cytokinetics
$22.15 /

+0.38 (+1.75%)

NGM NGM Biopharmaceuticals
$20.37 /

+0.28 (+1.39%)

FLXN Flexion
$8.86 /

-0.28 (-3.06%)

HRMY Harmony Biosciences
$31.17 /

-0.83 (-2.59%)

  • 23
    Feb
  • 21
    Jan
  • 21
    Jan
  • 06
    Jan
  • 18
    Sep
  • 19
    Aug
  • 17
    Jul
  • 26
    Jun
QDEL Quidel
$111.29 /

-0.5 (-0.45%)

KDMN Kadmon
$3.83 /

-0.16 (-4.01%)

ONCS OncoSec
$3.40 /

+ (+0.00%)

ATHA Athira Pharma
$10.33 /

-0.42 (-3.91%)

QDEL Quidel
$111.29 /

-0.5 (-0.45%)

NGM NGM Biopharmaceuticals
$20.37 /

+0.28 (+1.39%)

FLXN Flexion
$8.86 /

-0.28 (-3.06%)

ONCS OncoSec
$3.40 /

+ (+0.00%)

ATHA Athira Pharma
$10.33 /

-0.42 (-3.91%)

Conference/Events
Everest Re to host virtual investor day » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
RE

Everest Re

$244.57 /

+0.94 (+0.39%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RE Everest Re
$244.57 /

+0.94 (+0.39%)

RE Everest Re
$244.57 /

+0.94 (+0.39%)

06/18/21
Fly Intel: Top five analyst downgrades
06/18/21 Citi
Everest Re downgraded to Neutral on valuation at Citi
06/18/21 Citi
Everest Re downgraded to Neutral from Buy at Citi
03/31/21 Citi
Everest Re price target raised to $287 from $275 at Citi
RE Everest Re
$244.57 /

+0.94 (+0.39%)

RE Everest Re
$244.57 /

+0.94 (+0.39%)

Conference/Events
GlaxoSmithKline to host conference call » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
GSK

GlaxoSmithKline

$39.08 /

-0.7 (-1.76%)

CEO Walmsley, CFO Mackay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$39.08 /

-0.7 (-1.76%)

GSK GlaxoSmithKline
$39.08 /

-0.7 (-1.76%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
GSK GlaxoSmithKline
$39.08 /

-0.7 (-1.76%)

GSK GlaxoSmithKline
$39.08 /

-0.7 (-1.76%)

GSK GlaxoSmithKline
$39.08 /

-0.7 (-1.76%)

GSK GlaxoSmithKline
$39.08 /

-0.7 (-1.76%)

Conference/Events
Johnson & Johnson to hold an investor update conference call » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
JNJ

Johnson & Johnson

$163.68 /

-0.15 (-0.09%)

Management holds an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$163.68 /

-0.15 (-0.09%)

JNJ Johnson & Johnson
$163.68 /

-0.15 (-0.09%)

06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
06/08/21 Wedbush
Argenx price target lowered to $344 from $356 at Wedbush
06/08/21 Baird
Argenx price target lowered to $333 from $346 at Baird
06/07/21 BofA
BofA upgrades Biogen to Neutral with $400 price target after Aduhelm approved
JNJ Johnson & Johnson
$163.68 /

-0.15 (-0.09%)

JNJ Johnson & Johnson
$163.68 /

-0.15 (-0.09%)

JNJ Johnson & Johnson
$163.68 /

-0.15 (-0.09%)

JNJ Johnson & Johnson
$163.68 /

-0.15 (-0.09%)

Conference/Events
Tactile Systems management to meet virtually with Piper Sandler » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
TCMD

Tactile Systems

$53.76 /

+2.2 (+4.27%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCMD Tactile Systems
$53.76 /

+2.2 (+4.27%)

03/30/21 Piper Sandler
Tactile Systems granted partial favorable judgment, says Piper Sandler
02/24/21 Piper Sandler
Tactile Systems valuation attractive despite guidance, says Piper Sandler
01/25/21 BTIG
Tactile Systems price target raised to $60 from $51 at BTIG
11/13/20 Oppenheimer
Tactile Systems upgraded to Outperform from Perform at Oppenheimer
TCMD Tactile Systems
$53.76 /

+2.2 (+4.27%)

Conference/Events
MediciNova participates in a conference call with Maxim » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
MNOV

MediciNova

$4.02 /

-0.165 (-3.95%)

Healthcare Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNOV MediciNova
$4.02 /

-0.165 (-3.95%)

MNOV MediciNova
$4.02 /

-0.165 (-3.95%)

03/10/21
Fly Intel: Top five analyst initiations
03/10/21 Maxim
MediciNova initiated with a Buy at Maxim
03/10/21 Maxim
MediciNova initiated with a Buy at Maxim
MNOV MediciNova
$4.02 /

-0.165 (-3.95%)

Conference/Events
Universal Technical management to meet virtually with B. Riley » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
UTI

Universal Technical

$5.62 /

+0.2 (+3.69%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UTI Universal Technical
$5.62 /

+0.2 (+3.69%)

UTI Universal Technical
$5.62 /

+0.2 (+3.69%)

12/30/20 B. Riley Securities
B. Riley reiterates $11 target on Universal Technical after acquisition
11/19/20 Lake Street
Universal Tech's progress proves resilience of business model, says Lake Street
09/25/20
Fly Intel: Top analyst downgrades
09/25/20 Argus
Argus cuts Universal Technical to Hold on pressures from pandemic
UTI Universal Technical
$5.62 /

+0.2 (+3.69%)

Conference/Events
Ingersoll-Rand participates in a conference call with Ingersoll Rand » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
IR

Ingersoll-Rand

$46.60 /

-0.35 (-0.75%)

Barclays holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IR Ingersoll-Rand
$46.60 /

-0.35 (-0.75%)

IR Ingersoll-Rand
$46.60 /

-0.35 (-0.75%)

06/22/21 Baird
Ingersoll-Rand remains a top idea, says Baird
06/17/21 Vertical Research
Ingersoll-Rand upgraded to Buy from Hold at Vertical Research
06/17/21 Vertical Research
Ingersoll-Rand upgraded to Buy from Hold at Vertical Research
06/14/21 Credit Suisse
Ingersoll-Rand reinstated with a Neutral at Credit Suisse
IR Ingersoll-Rand
$46.60 /

-0.35 (-0.75%)

  • 11
    May
IR Ingersoll-Rand
$46.60 /

-0.35 (-0.75%)

IR Ingersoll-Rand
$46.60 /

-0.35 (-0.75%)

Conference/Events
Goldman Sachs to hold a virtual conference » 04:55
06/23/21
06/23
04:55
06/23/21
04:55

17th Business Services,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
TCR2 Therapeutics management to meet virtually with Mizuho » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
TCRR

TCR2 Therapeutics

$17.23 /

-0.06 (-0.35%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCRR TCR2 Therapeutics
$17.23 /

-0.06 (-0.35%)

TCRR TCR2 Therapeutics
$17.23 /

-0.06 (-0.35%)

06/11/21 BMO Capital
TCR2 Therapeutics coverage transferred at BMO Capital
05/14/21 Wedbush
TCR2 Therapeutics price target lowered to $45 from $57 at Wedbush
03/12/21 Mizuho
TCR2 Therapeutics price target lowered to $51 from $58 at Mizuho
03/11/21 BMO Capital
TCR2 Therapeutics price target lowered to $56 from $65 at BMO Capital
TCRR TCR2 Therapeutics
$17.23 /

-0.06 (-0.35%)

  • 20
    Jan
  • 29
    Jul
Conference/Events
Identiv management to meet virtually with Lake Street » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
INVE

Identiv

$15.87 /

-0.69 (-4.17%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INVE Identiv
$15.87 /

-0.69 (-4.17%)

INVE Identiv
$15.87 /

-0.69 (-4.17%)

06/07/21 B. Riley
Identiv price target raised to $22 from $21 at B. Riley
04/14/21 Lake Street
Identiv price target raised to $17 from $13 at Lake Street
04/13/21 B. Riley
B. Riley starts Identiv at Buy, sees 82% upside in shares
04/12/21 B. Riley
Identiv initiated with a Buy at B. Riley
INVE Identiv
$15.87 /

-0.69 (-4.17%)

  • 08
    Apr
Conference/Events
Ensign Group participates in a conference call with Stephens » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
ENSG

Ensign Group

$85.07 /

+0.68 (+0.81%)

Healthcare Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENSG Ensign Group
$85.07 /

+0.68 (+0.81%)

ENSG Ensign Group
$85.07 /

+0.68 (+0.81%)

06/22/21 Stifel
Ensign Group resumed with a Buy at Stifel
06/17/21 Stephens
Supreme Court ruling removes overhang on ACA levered stocks, says Stephens
05/03/21 RBC Capital
Ensign Group price target raised to $100 from $95 at RBC Capital
04/16/21 Stephens
Humana named a new Best Idea for 2021 at Stephens
ENSG Ensign Group
$85.07 /

+0.68 (+0.81%)

Conference/Events
JPMorgan media analyst to hold an analyst/industry conference call » 04:55
06/23/21
06/23
04:55
06/23/21
04:55

Media Analyst Quadrani…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Domo participates in a conference call with Needham » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
DOMO

Domo

$78.33 /

-2.1 (-2.61%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DOMO Domo
$78.33 /

-2.1 (-2.61%)

DOMO Domo
$78.33 /

-2.1 (-2.61%)

05/28/21 Needham
Domo price target raised to $93 from $91 at Needham
03/15/21 Credit Suisse
Domo assumed with a Neutral at Credit Suisse
03/15/21
Fly Intel: Top five analyst upgrades
03/15/21 UBS
Domo upgraded to Buy from Neutral at UBS
DOMO Domo
$78.33 /

-2.1 (-2.61%)

DOMO Domo
$78.33 /

-2.1 (-2.61%)

DOMO Domo
$78.33 /

-2.1 (-2.61%)

Conference/Events
UBS to hold a virtual conference » 04:55
06/23/21
06/23
04:55
06/23/21
04:55

Taiwan Virtual Conference…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Advanced Drainage management to meet virtually with Loop Capital » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
WMS

Advanced Drainage

$108.58 /

+1.52 (+1.42%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
WMS Advanced Drainage
$108.58 /

+1.52 (+1.42%)

WMS Advanced Drainage
$108.58 /

+1.52 (+1.42%)

05/21/21 Loop Capital
Advanced Drainage price target raised to $127 from $120 at Loop Capital
05/21/21 Barclays
Advanced Drainage price target raised to $130 from $128 at Barclays
04/21/21 Barclays
Advanced Drainage price target raised to $128 from $115 at Barclays
02/11/21 Morgan Stanley
Morgan Stanley upgrades Advanced Drainage to Equal Weight, nearly doubles target
WMS Advanced Drainage
$108.58 /

+1.52 (+1.42%)

  • 11
    Dec
Conference/Events
Jounce Therapeutics to host virtual research and development day » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
JNCE

Jounce Therapeutics

$7.42 /

-0.33 (-4.26%)

Research and Development…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

  • 10
    Mar
JNCE Jounce Therapeutics
$7.42 /

-0.33 (-4.26%)

Conference/Events
H.C. Wainwright biotech analysts to hold analyst/industry conference call » 04:55
06/23/21
06/23
04:55
06/23/21
04:55

Biotechnology Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Vipshop participates in a conference call with Benchmark » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
VIPS

Vipshop

$17.51 /

-0.135 (-0.77%)

***NEW DATE of June…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIPS Vipshop
$17.51 /

-0.135 (-0.77%)

VIPS Vipshop
$17.51 /

-0.135 (-0.77%)

05/20/21 HSBC
Vipshop price target lowered to $25 from $30 at HSBC
04/15/21 JPMorgan
Vipshop upgraded to Overweight from Neutral at JPMorgan
02/26/21 Macquarie
Vipshop price target raised to $52 from $33 at Macquarie
02/01/21 Morgan Stanley
Vipshop user engagement to underpin 'solid' user growth, says Morgan Stanley
VIPS Vipshop
$17.51 /

-0.135 (-0.77%)

  • 06
    Apr
VIPS Vipshop
$17.51 /

-0.135 (-0.77%)

VIPS Vipshop
$17.51 /

-0.135 (-0.77%)

VIPS Vipshop
$17.51 /

-0.135 (-0.77%)

Conference/Events
Brooks Automation participates in a conference call with Stephens » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
BRKS

Brooks Automation

$93.83 /

-0.075 (-0.08%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRKS Brooks Automation
$93.83 /

-0.075 (-0.08%)

BRKS Brooks Automation
$93.83 /

-0.075 (-0.08%)

05/11/21 Needham
Brooks Automation price target raised to $130 from $110 at Needham
05/11/21 Credit Suisse
Brooks Automation price target raised to $85 from $70 at Credit Suisse
05/11/21 B. Riley
Brooks Automation price target raised to $130 from $125 at B. Riley
05/07/21 Needham
Brooks Automation assumed with a Buy at Needham
BRKS Brooks Automation
$93.83 /

-0.075 (-0.08%)

BRKS Brooks Automation
$93.83 /

-0.075 (-0.08%)

BRKS Brooks Automation
$93.83 /

-0.075 (-0.08%)

Conference/Events
Roth Capital to hold a virtual conference » 04:55
06/23/21
06/23
04:55
06/23/21
04:55
ACMR

ACM Research

$102.72 /

+5.89 (+6.08%)

, AEVA

Aeva Technologies

$10.54 /

-0.495 (-4.49%)

, AKTS

Akoustis

$10.47 /

+0.025 (+0.24%)

, ARRY

Array Technologies

$15.65 /

+0.065 (+0.42%)

, BIOX

Bioceres

$13.11 /

-0.21 (-1.58%)

, CLSK

CleanSpark

$16.64 /

-0.51 (-2.97%)

, DQ

Daqo New Energy

$56.46 /

-2.22 (-3.78%)

, ENPH

Enphase Energy

$167.35 /

+4.24 (+2.60%)

, EVGN

Evogene

$3.44 /

-0.06 (-1.71%)

, FSLR

First Solar

$78.37 /

+0.06 (+0.08%)

, HASI

Hannon Armstrong

$54.14 /

+0.5 (+0.93%)

, JKS

JinkoSolar

$37.14 /

-4.105 (-9.95%)

, MAXN

Maxeon Solar

$17.97 /

+0.27 (+1.53%)

, NOVA

Sunnova Energy

$35.37 /

+1.16 (+3.39%)

, PNG

Bought by PAA

$23.00 /

+ (+0.00%)

, RUN

Sunrun

$52.43 /

+2.245 (+4.47%)

, SEDG

SolarEdge

$260.56 /

+2.16 (+0.84%)

, THBR

Thunder Bridge Acquisition II

$10.89 /

+ (+0.00%)

, WATT

Energous

$2.76 /

-0.005 (-0.18%)

Virtual London Conference…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACMR ACM Research
$102.72 /

+5.89 (+6.08%)

AEVA Aeva Technologies
$10.54 /

-0.495 (-4.49%)

AKTS Akoustis
$10.47 /

+0.025 (+0.24%)

ARRY Array Technologies
$15.65 /

+0.065 (+0.42%)

BIOX Bioceres
$13.11 /

-0.21 (-1.58%)

CLSK CleanSpark
$16.64 /

-0.51 (-2.97%)

DQ Daqo New Energy
$56.46 /

-2.22 (-3.78%)

ENPH Enphase Energy
$167.35 /

+4.24 (+2.60%)

EVGN Evogene
$3.44 /

-0.06 (-1.71%)

FSLR First Solar
$78.37 /

+0.06 (+0.08%)

HASI Hannon Armstrong
$54.14 /

+0.5 (+0.93%)

JKS JinkoSolar
$37.14 /

-4.105 (-9.95%)

MAXN Maxeon Solar
$17.97 /

+0.27 (+1.53%)

NOVA Sunnova Energy
$35.37 /

+1.16 (+3.39%)

RUN Sunrun
$52.43 /

+2.245 (+4.47%)

SEDG SolarEdge
$260.56 /

+2.16 (+0.84%)

THBR Thunder Bridge Acquisition II
$10.89 /

+ (+0.00%)

WATT Energous
$2.76 /

-0.005 (-0.18%)

ACMR ACM Research
$102.72 /

+5.89 (+6.08%)

06/14/21 Roth Capital
ACM Research hits another milestone in STAR IPO plan, says Roth Capital
05/07/21 Roth Capital
ACM Research price target lowered to $110 from $130 at Roth Capital
12/16/20 Roth Capital
ACM listing in China set for Q1 with Verification Report, says Roth Capital
10/27/20 Jefferies
ACM Research initiated with a Buy at Jefferies
AEVA Aeva Technologies
$10.54 /

-0.495 (-4.49%)

05/06/21 Roth Capital
Key enhancement affirms Aeva strategic LIDAR Roadmap, says Roth Capital
03/31/21 Baird
Aeva Technologies initiated with an Outperform at Baird
03/19/21
Fly Intel: Top five analyst initiations
03/18/21 Oppenheimer
Oppenheimer starts Aeva Technologies at Outperform with $20 price target
AKTS Akoustis
$10.47 /

+0.025 (+0.24%)

05/04/21 Lake Street
Akoustis price target lowered to $14 from $19 at Lake Street
05/03/21 Roth Capital
Akoustis price target lowered to $16 from $25 at Roth Capital
03/30/21 Roth Capital
Akoustis secures WiFi 6e reference design win, says Roth Capital
02/23/21 Roth Capital
Akoustis equity financing improves balance sheet, says Roth Capital
ARRY Array Technologies
$15.65 /

+0.065 (+0.42%)

05/24/21 Barclays
Array Technologies price target lowered to $15 from $16 at Barclays
05/24/21 Barclays
FTC Solar initiated with an Equal Weight at Barclays
05/12/21 Credit Suisse
Array Technologies upgraded to Outperform at Credit Suisse following pullback
05/12/21 Credit Suisse
Array Technologies upgraded to Outperform from Neutral at Credit Suisse
BIOX Bioceres
$13.11 /

-0.21 (-1.58%)

04/08/21 Lake Street
Bioceres price target raised to $20 from $15 at Lake Street
03/15/21 Lake Street
Bioceres initiated with a Buy at Lake Street
CLSK CleanSpark
$16.64 /

-0.51 (-2.97%)

03/10/21 BTIG
CleanSpark initiated with a Buy at BTIG
03/10/21 BTIG
CleanSpark initiated with a Buy at BTIG
02/16/21 H.C. Wainwright
CleanSpark price target raised to $50 from $24 at H.C. Wainwright
12/11/20 H.C. Wainwright
CleanSpark price target raised to $24 from $18 at H.C. Wainwright
DQ Daqo New Energy
$56.46 /

-2.22 (-3.78%)

06/10/21 HSBC
Daqo New Energy initiated with a Buy at HSBC
06/07/21 JPMorgan
Daqo New Energy downgraded to Neutral at JPMorgan
06/07/21 JPMorgan
Daqo New Energy downgraded to Neutral from Overweight at JPMorgan
06/01/21 Roth Capital
Daqo New Energy price target raised to $79 from $70 at Roth Capital
ENPH Enphase Energy
$167.35 /

+4.24 (+2.60%)

06/21/21 Capital One
Enphase Energy downgraded to Equalweight from Overweight at Capital One
06/02/21 Guggenheim
SolarEdge initiated with a Buy at Guggenheim on potential of storage offering
06/02/21 Guggenheim
Guggenheim starts Enphase Energy at Neutral, sees valuation as full
06/02/21 Guggenheim
Enphase Energy initiated with a Neutral at Guggenheim
EVGN Evogene
$3.44 /

-0.06 (-1.71%)

11/30/20 Cantor Fitzgerald
Cantor Fitzgerald starts 'highly underappreciated' Evogene at Overweight
11/30/20 Cantor Fitzgerald
Evogene initiated with an Overweight at Cantor Fitzgerald
FSLR First Solar
$78.37 /

+0.06 (+0.08%)

06/10/21 Citi
First Solar estimates raised on new facility in Ohio at Citi
06/09/21 Roth Capital
Roth Capital sees First Solar's Ohio factory plans as 'a positive' for stock
05/03/21
Fly Intel: Top five analyst upgrades
05/03/21 BofA
First Solar upgraded to Buy following post-earnings pullback at BofA
HASI Hannon Armstrong
$54.14 /

+0.5 (+0.93%)

04/29/21 BofA
BofA downgrades Hannon Armstrong to Underperform on limited valuation upside
04/29/21 BofA
Hannon Armstrong downgraded to Underperform from Neutral at BofA
03/08/21 JPMorgan
Hannon Armstrong price target lowered to $66 from $74 at JPMorgan
02/22/21 Baird
Hannon Armstrong price target raised to $61 from $58 at Baird
JKS JinkoSolar
$37.14 /

-4.105 (-9.95%)

04/16/21 UBS
JinkoSolar upgraded to Neutral from Sell at UBS
04/12/21 GLJ Research
JinkoSolar businss model 'simply not sustainable,' says GLJ Research
04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 Roth Capital
JinkoSolar downgraded to Neutral from Buy at Roth Capital
MAXN Maxeon Solar
$17.97 /

+0.27 (+1.53%)

06/01/21 Roth Capital
Maxeon Solar price target lowered to $16 from $23 at Roth Capital
05/28/21 Roth Capital
Maxeon Solar price target lowered to $16 from $23 at Roth Capital
05/06/21 Raymond James
Maxeon Solar upgraded to Strong Buy from Outperform at Raymond James
05/06/21 Raymond James
Maxeon Solar upgraded to Strong Buy from Outperform at Raymond James
NOVA Sunnova Energy
$35.37 /

+1.16 (+3.39%)

06/15/21 Roth Capital
Sunnova Energy secures low spread in ABS refinancing, says Roth Capital
06/02/21 Guggenheim
Sunnova should be able to add subscribers, says Guggenheim
06/02/21 Guggenheim
Sunnova Energy initiated with a Buy at Guggenheim
06/01/21 Roth Capital
Watering down of AB1139 positive for residential solar, says Roth Capital
PNG Bought by PAA
$23.00 /

+ (+0.00%)

RUN Sunrun
$52.43 /

+2.245 (+4.47%)

06/16/21 Morgan Stanley
Sunrun price target raised to $91 from $86 at Morgan Stanley
06/02/21 Guggenheim
Sunrun assumed with a Buy at Guggenheim
06/01/21 Roth Capital
Watering down of AB1139 positive for residential solar, says Roth Capital
05/07/21 Truist
Sunrun price target lowered to $81 from $95 at Truist
SEDG SolarEdge
$260.56 /

+2.16 (+0.84%)

06/02/21 Guggenheim
SolarEdge initiated with a Buy at Guggenheim on potential of storage offering
06/02/21 Guggenheim
Guggenheim starts Enphase Energy at Neutral, sees valuation as full
06/02/21 Guggenheim
SolarEdge initiated with a Buy at Guggenheim
06/01/21 Roth Capital
Watering down of AB1139 positive for residential solar, says Roth Capital
THBR Thunder Bridge Acquisition II
$10.89 /

+ (+0.00%)

05/28/21 Benchmark
Thunder Bridge Acquisition II assumed with a Buy at Benchmark
03/12/21
Fly Intel: Top five analyst initiations
03/12/21 Roth Capital
Thunder Bridge Acquisition II initiated with a Buy at Roth Capital
03/09/21
Fly Intel: Top five analyst initiations
WATT Energous
$2.76 /

-0.005 (-0.18%)

04/26/21 Roth Capital
Energous CEO leave to have limited impact, says Roth Capital
12/15/20 Roth Capital
Roth Capital backs Buy rating on Energous after securing FCC approval
12/02/20 Roth Capital
Roth keeps Buy rating on Energous as EU hearing aid customer identity revealed
08/19/20 Roth Capital
Energous partnership affirms expanding opportunity, says Roth Capital
ACMR ACM Research
$102.72 /

+5.89 (+6.08%)

AEVA Aeva Technologies
$10.54 /

-0.495 (-4.49%)

AKTS Akoustis
$10.47 /

+0.025 (+0.24%)

ARRY Array Technologies
$15.65 /

+0.065 (+0.42%)

BIOX Bioceres
$13.11 /

-0.21 (-1.58%)

CLSK CleanSpark
$16.64 /

-0.51 (-2.97%)

DQ Daqo New Energy
$56.46 /

-2.22 (-3.78%)

ENPH Enphase Energy
$167.35 /

+4.24 (+2.60%)

FSLR First Solar
$78.37 /

+0.06 (+0.08%)

HASI Hannon Armstrong
$54.14 /

+0.5 (+0.93%)

JKS JinkoSolar
$37.14 /

-4.105 (-9.95%)

MAXN Maxeon Solar
$17.97 /

+0.27 (+1.53%)

NOVA Sunnova Energy
$35.37 /

+1.16 (+3.39%)

RUN Sunrun
$52.43 /

+2.245 (+4.47%)

SEDG SolarEdge
$260.56 /

+2.16 (+0.84%)

WATT Energous
$2.76 /

-0.005 (-0.18%)

  • 16
    Apr
  • 19
    Mar
  • 16
    Mar
  • 16
    Dec
  • 15
    Dec
  • 03
    Dec
  • 01
    Dec
  • 12
    Nov
  • 21
    Oct
  • 15
    Oct
  • 13
    Oct
  • 07
    Oct
  • 17
    Sep
  • 14
    Aug
  • 01
    Jul
CLSK CleanSpark
$16.64 /

-0.51 (-2.97%)

DQ Daqo New Energy
$56.46 /

-2.22 (-3.78%)

FSLR First Solar
$78.37 /

+0.06 (+0.08%)

JKS JinkoSolar
$37.14 /

-4.105 (-9.95%)

ACMR ACM Research
$102.72 /

+5.89 (+6.08%)

AEVA Aeva Technologies
$10.54 /

-0.495 (-4.49%)

AKTS Akoustis
$10.47 /

+0.025 (+0.24%)

ARRY Array Technologies
$15.65 /

+0.065 (+0.42%)

BIOX Bioceres
$13.11 /

-0.21 (-1.58%)

CLSK CleanSpark
$16.64 /

-0.51 (-2.97%)

DQ Daqo New Energy
$56.46 /

-2.22 (-3.78%)

ENPH Enphase Energy
$167.35 /

+4.24 (+2.60%)

FSLR First Solar
$78.37 /

+0.06 (+0.08%)

HASI Hannon Armstrong
$54.14 /

+0.5 (+0.93%)

JKS JinkoSolar
$37.14 /

-4.105 (-9.95%)

MAXN Maxeon Solar
$17.97 /

+0.27 (+1.53%)

NOVA Sunnova Energy
$35.37 /

+1.16 (+3.39%)

RUN Sunrun
$52.43 /

+2.245 (+4.47%)

SEDG SolarEdge
$260.56 /

+2.16 (+0.84%)

WATT Energous
$2.76 /

-0.005 (-0.18%)

AEVA Aeva Technologies
$10.54 /

-0.495 (-4.49%)

AKTS Akoustis
$10.47 /

+0.025 (+0.24%)

BIOX Bioceres
$13.11 /

-0.21 (-1.58%)

CLSK CleanSpark
$16.64 /

-0.51 (-2.97%)

DQ Daqo New Energy
$56.46 /

-2.22 (-3.78%)

ENPH Enphase Energy
$167.35 /

+4.24 (+2.60%)

EVGN Evogene
$3.44 /

-0.06 (-1.71%)

FSLR First Solar
$78.37 /

+0.06 (+0.08%)

JKS JinkoSolar
$37.14 /

-4.105 (-9.95%)

MAXN Maxeon Solar
$17.97 /

+0.27 (+1.53%)

RUN Sunrun
$52.43 /

+2.245 (+4.47%)

SEDG SolarEdge
$260.56 /

+2.16 (+0.84%)

THBR Thunder Bridge Acquisition II
$10.89 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.